AdvisorShares Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
+7,810
New +$1.2M 0.22% 70
2025
Q1
Sell
-4,360
Closed -$424K 309
2024
Q4
$424K Buy
+4,360
New +$465K 0.08% 170
2020
Q4
Sell
-5,049
Closed -$439 159
2020
Q3
$439 Sell
5,049
-337
-6% -$29.2K 0.02% 97
2020
Q2
$470K Sell
5,386
-672
-11% -$58K 0.2% 94
2020
Q1
$499K Sell
6,058
-337
-5% -$30.1K 0.43% 53
2019
Q4
$606K Buy
+6,395
New +$574K 0.38% 98

Other funds holding NVS

AdvisorShares Investments's NVS Position: Q1 2026 in Review

AdvisorShares Investments opened a new position in Novartis (NVS) in Q1 2026: 7,810 shares worth $1.19M. The stake represents 0.22% of the portfolio and ranks #70 among its holdings. This is a return to the name: AdvisorShares Investments previously reported a position in NVS as recently as Q4 2024.

AdvisorShares Investments first reported a position in NVS in Q4 2019 and has held it in 6 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • AdvisorShares Investments held 7,810 shares of Novartis worth $1.19M as of Q1 2026.
  • Novartis was a new AdvisorShares Investments position in Q1 2026.
  • Novartis made up 0.22% of AdvisorShares Investments's portfolio in Q1 2026, its #70 holding.
  • AdvisorShares Investments first reported a position in Novartis in Q4 2019 and has held it in 6 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.